Integra Lifesciences reported $71.25M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 1862M 248M
Abiomed ABMD:US $ 66.2M 3.4M
Atricure ATRC:US $ -15077000 808K
Baxter International BAX:US $ 476M 50M
Becton, Dickinson and BDX:US $ 526M 326M
Biotelemetry BEAT:US $ -337000 15.41M
Boston Scientific BSX:US $ 576M 203M
Conmed CNMD:US $ 25.71M 4.55M
Cooper Companies COO:US $ 100.6M 48.6M
Dexcom DXCM:US $ 101M 55.1M
Edwards Lifesciences EW:US $ 544.5M 154.6M
Globus Medical GMED:US $ 59.75M 5.02M
Hologic HOLX:US $ 362.2M 421.5M
Insulet PODD:US $ 26.3M 10M
Integra Lifesciences IART:US $ 71.25M 13.35M
Intuitive Surgical ISRG:US $ 511.2M 94.4M
Johnson & Johnson JNJ:US $ 6901M 94M
Medtronic MDT:US $ 896M 1101M
Merit Medical Systems MMSI:US $ 26.62M 12.42M
Nuvasive NUVA:US $ 22.3M 4.38M
Orthofix International OFIX:US $ 7.85M 9.76M
Stryker SYK:US $ 843M 253M
Tandem Diabetes Care TNDM:US $ 5.43M 8.67M
Teleflex TFX:US $ 151.61M 32.18M
Zimmer Biomet Holdings Inc ZBH:US $ 302.5M 20M